Incannex Healthcare (IXHL) Equity Income (2025 - 2026)
Incannex Healthcare's (IXHL) quarterly Equity Income came in at -$44000.0 in Q1 2026, down 500.0% quarter-over-quarter from $11000.0 in Q4 2025.
Incannex Healthcare (IXHL) Equity Income (2025 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Equity Income across 2 years of filings, most recently posting -$44000.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -1.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 25.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -9.68 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.91 Mn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 6,000.00 |